Search Results 1341-1350 of 19457 for Hemoglobin

1. Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma - Mayo Clinic

   Hemoglobin ≥ 10 g/dL (RBC transfusion allowed); Not pregnant or nursing; Negative pregnancy test; Fertile patients must use contraception; No known HIV ...

2. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x IULN; AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN, or ≤ 5.0 x IULN if due to liver involvement by tumor; Creatinine ...

3. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Subject has a history of diabetes mellitus type 1, or uncontrolled diabetes mellitus type 2 with hemoglobin A1c (HbA1c) > 9%, or is a diabetic subject with ...

4. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   Absolute neutrophil count ≥ 1,000 cells/mm3 without growth factors (within 14 days of enrollment). Hemoglobin ≥ 8 g/dL (within 14 days of enrollment) ...

5. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; Total bilirubin ≤ 1.5 institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...

6. A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

   Hemoglobin ≥ 8 g/dL without transfusion or growth factor support within 7 days of the first dose of study drug;; Platelet count ≥ 50 x 10^9/L without ...

7. A Study of MTI-301 in Patients with Advanced Malignancy - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 9.0 g/dL · Absolute neutrophil count (ANC) ≥ 1500/mm3 · Platelet count ≥ 100,000/mm3 · Total bilirubin ≤ 1.5 x ULN.

8. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   ... hemoglobin value ≥ 8% at Screening. Screening value for hemoglobin < 12 g/dL for men or < 11 g/dL for women. Indication of impaired liver function as shown ...

9. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   - Hemoglobin (Hgb) ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable) - No prior invasive (except non-melanoma skin ...

10. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin >= 10 g/dL; Total bilirubin =< 1.5 x institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) serum glutamic-oxaloacetic ...